VivoSim Labs, INC. VIVS US Equity
$0.29
-0.01 (-2.63%)
USD · as of 2026-08-28 · marketstack
VivoSim Labs, INC. (Nasdaq: VIVS), an SEC filer in Biological Products, (No Diagnostic Substances), closed at $0.29, -2.6%, on 2026-08-28, with a market cap of $4M as of 2026-08-27, a return on equity of -35.3%, a net margin of -1727.8% and 3-year sales growth of -54.2%. Institutional ownership, earnings history and filed financials are on the tabs below.
Short interest· FINRA consolidated · settlement 2026-08-14
6 settlement cycles| Shares short | 751K |
| % of shares out | 5.1% |
| Days to cover | 1.0 |
| Δ vs 2026-07-31 | +31.7% |
bars = shares short · line = days to cover (own scale)
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.